España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Frank Sylvester
Benzinga Staff Writer
UPDATE: JP Morgan Lowers PT on TIBCO Software, Management Blames Sales Execution for Poor Results
UPDATE: Oppenheimer Raises PT to $48 on HCA and Reiterates Outperform Rating
UPDATE: Oppenheimer Raises PT on Life Point Hospitals and Reiterates Perform Rating
UPDATE: Oppenheimer Raises PT on Health Management Associates and Reiterates Outperform Rating
UPDATE: JP Morgan Lowers PT on Edwards Lifesciences on Sapien US Launch
UPDATE: Wedbush Reduces PT on TIBCO Software on 1Q Miss
UPDATE: Deutsche Bank Upgrades Family Dollar Stores to Buy on Sentiment
UPDATE: Deutsche Bank Downgrades Kohl's to Sell on Weakening Traffic
UPDATE: Itau BBA Upgrades America Movil to Market-Perform on Proposed T&B Bill
UPDATE: JP Morgan Initiates Healthcare Trust of America at Neutral on Single Digit Core Growth
UPDATE: Canaccord Genuity Initiates Insmed at Buy on New Treatment for Lung Infections
UPDATE: Goldman Sachs Resumes Ascena Retail Group at Neutral, Like Brand Positioning
UPDATE: Goldman Sachs Resumes Gildan Activewear at Neutral on Price-Performance
Goldman Sachs Resumes on Carter's at Neutral on Valuation
Goldman Sachs Resumes The Children's Place at Sell on Increasing Competition
UPDATE: Goldman Sachs Initiates Hanesbrands at Buy on Valuation
UPDATE: Goldman Sachs Initiates Coverage on Healthcare Realty with a Sell Rating on Valuation
UPDATE: Goldman Sachs Resumes Coverage on Ventas with a Buy Rating on Favorable Fundamentals
UPDATE: Goldman Sachs Initiates Medical Properties Trust at Buy on Valuation
UPDATE: Goldman Sachs Initiates Omega Healthcare Investors at Buy on Attractive Valuation